Cancer, a deadly disease, is a condition where cells of any body part start growing without control. The cells further divide and grow to spread into other body parts. In a healthy body, old or damaged cells die while other cells divide and form new cells.
Cancer disturbs this process; new cells are formed when not required. These new cells divide and divide, forming tumors. Cancer like leukemia’s develops solid tumors, while blood cancer does not form any tumor.
Renal cell carcinoma (RCC) or kidney cancer is one of the common types of kidney cancer. Usually, kidney cancer starts with a single tumor in the kidney or two tumors, each in both the kidneys.
The kidney is the bean-shaped body part, which take care of purifying the blood. Kidneys remove excess salts, water, and other chemical wastes from the blood and eject them from the body through urine. Since every blood drop enters the kidneys, it is easy for the cancer cells to spread to the kidneys.
The survival rate of RCC is above 70% for at least five years. RCC can be cured with surgery or transplant.
Hepatocellular Carcinoma is chronic, the third leading reason for deaths across the world. Liver cancer is different from other cancers due to its functioning. In addition to the severity, this type of cancer forms solid tumors.
Liver cancers mostly occur in men than in women. Other diseases like Hepatitis B or Hepatitis C and hemochromatosis cause liver tumors. Other reasons, like excess alcohol and chronic liver inflammation, cause RCC.
RCC is diagnosed by several blood tests, imaging tests, i.e., CT and MRI, and a liver biopsy. Though liver cancer is critical to curing, specialists try to make it less painful by surgeries and liver transplant
The thyroid is a butterfly-shaped gland located in the lower part of the neck below the larynx. The thyroid controls the endocrine system of the body that controls the hormones in the body. There are five types of thyroid cancers.
Thyroid cancer usually starts with excess growth of cells in the thyroid gland and further spread to other parts. Though thyroid cancer is a common type of cancer, the reason behind the cause is unknown. Women and people with high radiation exposure tend to the risk of thyroid cancer.
Sorafekast is an anti-cancer medicine manufactured by BDR Pharmaceuticals International Pvt. Ltd. Sorafekast is best-known for its ability to fight tumors.
This drug helps fight cancer by stopping the growth of tumor cells, reduces the speed of blood flow, and speeds the self-destruction of cells.
According to the American Liver Foundation, more than 25 million Americans are afflicted with liver and gallbladder disease and more than 43,000 die of liver disease each year. While several factors contribute to liver damage, viral hepatitis is the single most important cause of liver disease in the United States and worldwide.
Roughly 200 million people worldwide are infected with the Hepatitis C virus (HCV). 4.9 million of those are in the United States (estimates go as high as 15 million) and 5 million in Western Europe. For every one person infected with the AIDS virus, there are more than four infected with Hepatitis C.
There are up to 230,000 new hepatitis C infections in the U.S. every year. Currently, 8,000 to 10,000 deaths each year are a result of HCV. Within the next 10-20 years, chronic hepatitis C is predicted to become a major burden on the health care system as patients with no symptoms progress to end-stage liver disease and develop hepatocellular carcinoma.
Predictions in the USA suggest that there will be a 60% increase in the incidence of cirrhosis, a 68% increase in hematoma incidence, a 528% increase in the need for transplantation, and a 223% increase in liver death rate. Supertoolsexpress
The roles of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in causing hepatocellular carcinoma (HCC) are well documented. The frequency of HCC correlates with chronic HBV infection rates. HCC is a cancer arising from the liver. It is also known as primary liver cancer or hematoma.
HCC is the fifth most common cancer in the world and the majority of patients with HCC will die within one year because of the cancer. The majority of primary liver cancers (over 90 to 95 %) arises from liver cells and is called hepatocellular cancer or carcinoma.
In 1990, the World Health Organization estimated that there were about 430,000 new cases of HCC worldwide, and a similar number of patients died resulting from this disease. Moreover, recent data show that the frequency of HCC in the U.S. overall is rising. Is there a way to curb this rise? Akrapower
While there is no cure for hepatitis and no completely effective treatment, the threats resulting from HCC, cirrhosis, and various hepatitis strands may best be combated by supporting.